Hematopoietic Stem Cell Transplantation Improves Pediatric SCD Outcomes
HCPLive
APRIL 9, 2024
A systematic review and meta-analysis of HSCT in children with sickle cell disease demonstrated pooled survival rates exceeding 90%.
59 
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients
DAIC
MARCH 6, 2024
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S., et al (2016).
Published Research
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Laurie Shroyer Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database The Annals of Thoracic Surgery November 2017 Michael Durheim Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease The Annals of Thoracic Surgery August 2017 Daniel Boffa Surgically Managed Clinical (..)
Published Research
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Laurie Shroyer Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database The Annals of Thoracic Surgery November 2017 Michael Durheim Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease The Annals of Thoracic Surgery August 2017 Daniel Boffa Surgically Managed Clinical (..)
Let's personalize your content